Roche Holding
(OTCQX:RHHBY)Latest News for Roche Holding Stock (OTC:RHHBY)
Roche Holding Stock (OTC: RHHBY)
Categories: All
Wednesday, April 24, 2024
Monday, April 15, 2024
- Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated PatientsVandana Singh - Apr 15, 2024, 8:56AM
- Roche's Genentech Announces That Columvi Met Its Primary Endpoint Of Overall Survival In People With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma In Phase III STARGLO StudyBenzinga Newsdesk - Apr 15, 2024, 1:34AM
Wednesday, April 10, 2024
Monday, April 08, 2024
Thursday, March 21, 2024
Wednesday, March 20, 2024
Friday, March 15, 2024
Tuesday, March 12, 2024
Monday, March 11, 2024
Friday, March 08, 2024
Tuesday, March 05, 2024
- Roche/Alnylam Blood Pressure Drug Aces In Mid-Stage Trial, Analyst Says Zilebesiran As Promising Opportunity In Addressing Global Hypertension ChallengesVandana Singh - Mar 5, 2024, 2:38PM
- Alnylam And Roche Initiated KARDIA-3 Phase 2 Study Of Zilebesiran Used As An Add-on Therapy For High Cardiovascular Risk And Uncontrolled Hypertension Despite Treatment With Two To Four Standard Antihypertensive MedicationsBenzinga Newsdesk - Mar 5, 2024, 7:42AM
- Alnylam/Roche Report KARDIA-2 Topline Study Results, The Study Met The Primary Endpoint Demonstrating Clinically Significant Blood Pressure Reductions When Zilebesiran is Added to Standard of Care AntihypertensivesBenzinga Newsdesk - Mar 5, 2024, 7:40AM
Wednesday, February 28, 2024
Monday, February 26, 2024
- 'Roche Explores Selling Lung Disease Drug Amid Buyer Interest' - Bloomberg NewsBenzinga Newsdesk - Feb 26, 2024, 11:40AM
- This Drug By Roche And Novartis Reduces Allergic Reactions Across Multiple Foods For People With Food AllergiesVandana Singh - Feb 26, 2024, 10:52AM
- Reported Earlier, Roche's Genentech Announced Data From Stage 1 Of The National Institutes Of Health (NIH)-Sponsored Pivotal Phase III Outmatch Study Evaluating The Efficacy And Safety Ofxolair®Benzinga Newsdesk - Feb 26, 2024, 3:11AM
Friday, February 16, 2024
Thursday, February 15, 2024
Tuesday, February 13, 2024
Thursday, February 01, 2024
Monday, January 29, 2024
Friday, January 26, 2024
Monday, January 22, 2024
Tuesday, January 16, 2024
- Roche's One Of Largest Selling Cancer Drug Approved Under The Skin Injection Version In EuropeVandana Singh - Jan 16, 2024, 11:38AM
- Merck's Crown Jewel Cancer Drug Keytruda Scores FDA Approval For Third Indication In Cervical CancerVandana Singh - Jan 16, 2024, 11:10AM
- Roche Receives European Commission Approval Of Tecentriq SC With Halozyme's ENHANZE Representing The EU's First Subcutaneous PD-(L)1 Cancer Immunotherapy For Multiple Cancer TypesBenzinga Newsdesk - Jan 16, 2024, 1:57AM
Wednesday, January 10, 2024
Tuesday, January 02, 2024
Thursday, December 21, 2023
Tuesday, December 19, 2023
- FDA Grants Priority Review To Xolair For Children And Adults With Food Allergies Based On National Institutes Of Health Phase III Study ResultsBenzinga Newsdesk - Dec 19, 2023, 9:42AM
- Roche navify Digital Solutions Earns Excellent Ratings From Healthcare Professionals In KLAS ResearchBenzinga Newsdesk - Dec 19, 2023, 2:06AM
Friday, December 15, 2023
Tuesday, December 12, 2023
Monday, December 11, 2023
- Poseida Therapeutics' New Treatment For Multiple Myeloma Shows Early Success In Clinical TrialVandana Singh - Dec 11, 2023, 11:17AM
- Roche's Genentech Presented New Data From Its CD20xCD3 T-Cell Engaging Bispecific Antibody Program At The 65th American Society Of Hematology (ASH) Annual MeetingBenzinga Newsdesk - Dec 11, 2023, 2:08AM
Wednesday, December 06, 2023
Tuesday, December 05, 2023
- While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal CancerUpwallstreet - Dec 5, 2023, 12:06PM
- Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With MutationVandana Singh - Dec 5, 2023, 8:30AM
- Roche's Genentech Announces Phase III Results For Inavolisib Combination In People With Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer With A PIK3CA MutationBenzinga Newsdesk - Dec 5, 2023, 1:07AM
Monday, December 04, 2023
- Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same NarrativeBenzinga Neuro - Dec 4, 2023, 8:24PM
- Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss DrugsVandana Singh - Dec 4, 2023, 7:04AM
- AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: ReportVandana Singh - Dec 4, 2023, 6:58AM